2,132
Views
73
CrossRef citations to date
0
Altmetric
Original Article

Effect of chromium and cobalt ions on primary human lymphocytes in vitro

, &
Pages 140-149 | Received 17 Aug 2010, Accepted 09 Jan 2011, Published online: 29 Mar 2011

Figures & data

Figure 1.  Cell viability of lymphocytes following 24 (upper) and 48 (lower) h of exposure to varying concentrations of Cr6+ and Co2+ ions, as measured by neutral red (NR) assay. (A and C) Resting and (B and D) anti-CD3-activated lymphocytes. A value of 100% indicates unexposed control cells; results are means ± SE (n = 18). *Significantly different from control values (at p < 0.05) by one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test. Significantly different from Co2+ values (at p < 0.05) by two-sample t-test.

Figure 1.  Cell viability of lymphocytes following 24 (upper) and 48 (lower) h of exposure to varying concentrations of Cr6+ and Co2+ ions, as measured by neutral red (NR) assay. (A and C) Resting and (B and D) anti-CD3-activated lymphocytes. A value of 100% indicates unexposed control cells; results are means ± SE (n = 18). *Significantly different from control values (at p < 0.05) by one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test. †Significantly different from Co2+ values (at p < 0.05) by two-sample t-test.

Figure 2.  T-lymphocyte proliferation following anti-CD3 ± anti-CD28 activation and exposure to varying concentrations of Cr6+ and Co2+ ions for 48 h. A value of 100% indicates unexposed control cells; results are means ± SE (n = 12). *Significantly different from control values (at p < 0.05) by one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test.

Figure 2.  T-lymphocyte proliferation following anti-CD3 ± anti-CD28 activation and exposure to varying concentrations of Cr6+ and Co2+ ions for 48 h. A value of 100% indicates unexposed control cells; results are means ± SE (n = 12). *Significantly different from control values (at p < 0.05) by one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test.

Figure 3.  IL-2 release from anti-CD3 ± anti-CD28 activated lymphocytes exposed to varying concentrations of Cr6+ and Co2+ ions for 48 h. Results are means ± SE (n = 3). *Significantly different from control values (at p < 0.05) by one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test.

Figure 3.  IL-2 release from anti-CD3 ± anti-CD28 activated lymphocytes exposed to varying concentrations of Cr6+ and Co2+ ions for 48 h. Results are means ± SE (n = 3). *Significantly different from control values (at p < 0.05) by one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test.

Figure 4.  IFNγ release from anti-CD3 ± anti-CD28 activated lymphocytes exposed to varying concentrations of Cr6+ and Co2+ ions for 48 h. Results are means ± SE (n = 3). *Significantly different from control values (at p < 0.05) by one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test.

Figure 4.  IFNγ release from anti-CD3 ± anti-CD28 activated lymphocytes exposed to varying concentrations of Cr6+ and Co2+ ions for 48 h. Results are means ± SE (n = 3). *Significantly different from control values (at p < 0.05) by one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test.

Figure 5.  Resting and anti-CD3 activated lymphocytes stained with annexin V and 7-AAD following exposure to 100 µM Cr6+ and 100 µM Co2+ for 24 h. Viable cells were annexin V and 7-AAD. Cells in early stages of apoptosis were annexin V+ but 7-AAD, whereas cells in late stages of apoptosis were both annexin V+ and 7-AAD+.

Figure 5.  Resting and anti-CD3 activated lymphocytes stained with annexin V and 7-AAD following exposure to 100 µM Cr6+ and 100 µM Co2+ for 24 h. Viable cells were annexin V− and 7-AAD−. Cells in early stages of apoptosis were annexin V+ but 7-AAD−, whereas cells in late stages of apoptosis were both annexin V+ and 7-AAD+.

Figure 6.  Total apoptosis in lymphocytes following 24 (upper) and 48 (lower) h of exposure to Cr6+ and Co2+. (A and C) Resting and (B and D) anti-CD3-activated lymphocytes. Results are mean (± SE; n = 6) proportion of lymphocytes expressing annexin V. A value of 100% indicates baseline apoptosis in unexposed control cells. *Significantly different from control values (at p < 0.05) by one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test. Significantly different from Co2+ values (at p < 0.05) by two-sample t-test.

Figure 6.  Total apoptosis in lymphocytes following 24 (upper) and 48 (lower) h of exposure to Cr6+ and Co2+. (A and C) Resting and (B and D) anti-CD3-activated lymphocytes. Results are mean (± SE; n = 6) proportion of lymphocytes expressing annexin V. A value of 100% indicates baseline apoptosis in unexposed control cells. *Significantly different from control values (at p < 0.05) by one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test. †Significantly different from Co2+ values (at p < 0.05) by two-sample t-test.

Figure 7.  Total apoptosis in lymphocytes (pre-treated for 24 h with/without caspase-3 inhibitor (50 µM Z.Devd.FMK)) following 24 h of exposure to Cr6+ or Co2+. (A and C) Resting and (B and D) anti-CD3-activated lymphocytes. Results are mean (± SE; n ≥ 3) proportion of lymphocytes expressing annexin V. A value of 100% indicates baseline apoptosis in unexposed control cells.

Figure 7.  Total apoptosis in lymphocytes (pre-treated for 24 h with/without caspase-3 inhibitor (50 µM Z.Devd.FMK)) following 24 h of exposure to Cr6+ or Co2+. (A and C) Resting and (B and D) anti-CD3-activated lymphocytes. Results are mean (± SE; n ≥ 3) proportion of lymphocytes expressing annexin V. A value of 100% indicates baseline apoptosis in unexposed control cells.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.